|
Pascual-Figal DA, Lax A, Bayes-Genis A. Reply: Interleukin-1beta and sST2. J Am Coll Cardiol. 2019 Jul 23;74(3):479-480. doi: 10.1016/j.jacc.2019.05.021. No abstract available. PubMed PMID: 31319926.
AÑO: 2019; IF: 20.589
|
31319926
|
Asensio Lopez MDC, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Aug 11;10(1):13553. doi: 10.1038/s41598-020-70454-8. Erratum In: Sci Rep. 2020 Oct 9;10(1):17266. PubMed PMID: 32782412; PubMed Central PMCID: PMC7419540.
AÑO: 2020; IF: 4.379
|
|
Asensio-Lopez MC, Sassi Y, Soler F, Fernandez Del Palacio MJ, Pascual-Figal D, Lax A. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI. Sci Rep. 2021 Feb 16;11(1):3915. doi: 10.1038/s41598-021-82745-9. PubMed PMID: 33594087; PubMed Central PMCID: PMC7887255.
AÑO: 2021; IF: 4.996
|
|
Del Carmen Asensio Lopez M, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Oct 9;10(1):17266. doi: 10.1038/s41598-020-73065-5. PubMed PMID: 33037250; PubMed Central PMCID: PMC7547718.
AÑO: 2020; IF: 4.379
|
|
Sanchez-Camara S, Asensio-Lopez MC, Royo-Villanova M, Soler F, Jara-Rubio R, Garrido-Penalver JF, Pinar E, Hernandez-Vicente A, Hurtado JA, Lax A, Pascual-Figal DA. Critical warm ischemia time point for cardiac donation after circulatory death. Am J Transplant. 2022 May;22(5):1321-1328. doi: 10.1111/ajt.16987. Epub 2022 Feb 21. PubMed PMID: 35114047; PubMed Central PMCID: PMC9303247.
AÑO: 2022; IF: 8.8
|